RxDoctor Payments Data

Andrew Emerson, DO

Family Medicine · Akron, OHNPI 1083155428

Payments from drug & device makers

$9,375in general payments, 2019–2025

Across 515 payments — averaging $18.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • AstraZeneca$864
  • GSK$721
  • Pfizer$707
  • Boehringer Ingelheim$679
  • Lilly USA, LLC$504
  • plus $4K from 42 others

What the payments were for

  • Food & beverage$9,375100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,375 in reported general payments places this provider in the 90th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$72,349
Medicare patients
223
Services billed
958

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide162$201,887
EliquisApixaban126$147,547
JardianceEmpagliflozin124$120,231
MounjaroTirzepatide59$81,534
TrulicityDulaglutide61$69,441
Trelegy ElliptaFluticasone/Umeclidin/Vilanter40$49,216
FarxigaDapagliflozin Propanediol31$37,082
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr40$32,596
XareltoRivaroxaban20$26,395
MyrbetriqMirabegron30$24,795
LinzessLinaclotide24$16,662
Breo ElliptaFluticasone/Vilanterol22$15,635
Tresiba Flextouch U-200Insulin Degludec18$9,639
Albuterol Sulfate HfaAlbuterol Sulfate216$7,584
Bevespi AerosphereGlycopyrrolate/Formoterol Fum15$7,260

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$481$201,887162 claims
Lilly USA, LLCMounjaro, Trulicity$504$150,974120 claims
PfizerEliquis$707$147,547126 claims
Boehringer IngelheimJardiance$679$120,231124 claims
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta$721$97,447102 claims
AstraZenecaFarxiga, Bevespi Aerosphere$864$44,34246 claims
Johnson & JohnsonXarelto$70$26,39520 claims
Astellas Pharma US IncMyrbetriq$46$24,79530 claims
AbbVieLinzess$1,973$16,66224 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Akron

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →